This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

18 F- Fluorodeoxyglucose (2017-01-24)

Starting date:
January 24, 2017
Posting date:
February 22, 2017
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-62312

Reason

Sterility testing did not meet specifications for the affected lots.

Affected products

18 F- Fluorodeoxyglucose

DIN, NPN, DIN-HIM

No market authorization

Dosage form

Liquid

Strength

65.2 Gbq (F01717)
72.4 Gbq (F01817)
59.1 Gbq (F02317)
12.2 Gbq (F02517)
47.2 Gbq (F03217)
76.6 Gbq (F03317)
72.8 Gbq (F03517)
FluGlucoScan Injection

Lot or serial number

F01717
F01817
F02317
F02517
F03217
F03317
F03517

Companies

Recalling Firm
Edmonton Radiopharmaceutical Centre
11560 University Avenue
Edmonton
T6G 1Z2
Alberta
CANADA
Marketing Authorization Holder
Edmonton Radiopharmaceutical Centre
11560 University Avenue
Edmonton
T6G 1Z2
Alberta
CANADA

Date modified: